Skip to main content
PHARMARESEARCH BIO Co., Ltd. logo

PHARMARESEARCH BIO Co., Ltd. — Investor Relations & Filings

Ticker · 217950 ISIN · KR7217950005 KO Manufacturing
Open in API
Filings indexed 162 across all filing types
Latest filing 2019-03-12 AGM Information
Country KR South Korea
Listing KO 217950

About PHARMARESEARCH BIO Co., Ltd.

http://www.pr-bio.co.kr/eng/

PHARMARESEARCH BIO Co., Ltd. is a biopharmaceutical company specializing in regenerative medicine. The company leverages marine biotechnology to research, develop, and produce innovative biological products aimed at enhancing human health. Its core activities center on the development of raw materials for cell and tissue regeneration, such as Polydeoxyribonucleotide (PDRN) and Polynucleotide (PN) derived from salmon DNA. The company's research and development pipeline also includes other biological products, such as toxin-based therapeutics, to address various medical and aesthetic needs.

Recent filings

Filing Released Lang Actions
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for PharmaResearchBio. It contains the meeting agenda, details on voting procedures, and financial statements (balance sheets) as part of the meeting materials. This type of document, which provides information to shareholders for an upcoming meeting, is classified as a Proxy Solicitation & Information Statement.
2019-03-12 Korean
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) regarding the 'Reason for holding a General Meeting of Shareholders on a concentrated date'. It explains why the company is holding its AGM on a date designated as a 'concentrated date' (a common regulatory requirement in the Korean market to prevent shareholder participation conflicts). Since this is a specific regulatory disclosure regarding meeting logistics and compliance rather than the meeting materials themselves, the proxy statement, or the voting results, it falls under the general regulatory filing category.
2019-03-12 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집 결의) for PharmaResearchBio. It outlines the date, location, and agenda items (such as financial statement approval, articles of incorporation changes, and director compensation). This type of document is a standard proxy solicitation or notice of meeting, which falls under the Proxy Solicitation & Information Statement category.
2019-03-05 Korean
전환가액의조정
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory filing regarding the adjustment of the conversion price of convertible bonds (전환가액의 조정) for PharmaResearchBio. This type of disclosure relates to changes in the company's capital structure and financing terms. Since it specifically details the adjustment of conversion prices for outstanding debt instruments, it falls under the category of Capital/Financing Update.
2019-01-18 Korean
기타주요경영사항(자율공시)
Regulatory Filings Classification · 95% confidence The document is a regulatory disclosure (자율공시) from PharmaResearchBio regarding the approval of a Phase 1 clinical trial for their product 'BCD200'. It details the purpose, mechanism, and future plans for the clinical trial. Since it does not fit into specific categories like financial reports, dividends, or M&A, and is a standard regulatory announcement of a material business event, it is classified as a Regulatory Filing (RNS).
2019-01-07 Korean
전환가액의조정
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory filing regarding the adjustment of the conversion price of convertible bonds (전환가액의 조정). It details the change in conversion price, the number of convertible shares, and the calculation methodology based on market price fluctuations. This falls under capital structure changes and financing updates, specifically related to convertible debt instruments.
2018-12-28 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.